SAB Biotherapeutics (SABS) Interest & Investment Income (2021 - 2026)
SAB Biotherapeutics' Interest & Investment Income came in at $1.71 million for Q2 2026, compared with $14,000 a year earlier and up 63.2% from the prior quarter.
Powered by 
Analysis
SAB Biotherapeutics (SABS) Interest & Investment Income (2021 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, SAB Biotherapeutics reported Interest & Investment Income of $4.11 million, up 739.1% year-over-year; for FY2025, it came in at $1.43 million, up 11.4% from FY2024.
- Interest & Investment Income has increased in each of the last four years, with a five-year compound annual growth rate of 122.7% (FY2020 to FY2025).
- Going back by year, Interest & Investment Income was $1.29 million in FY2024 (+119.8%), $584,966 in FY2023 (+723.1%), $71,072 in FY2022 (+207.5%) and $23,115 in FY2021 (-11.5%).
- The Q2 2026 figure represents the highest quarterly Interest & Investment Income in data going back to Q1 2021.
- Year-over-year, Interest & Investment Income increased in two of the last five quarters, with growth averaging 58.9%.
- The fastest year-over-year change in Interest & Investment Income over five years came in Q1 2024 (growth of 758.6%), and the weakest in Q2 2025 (a decline of 96.3%).
- Business Quant data shows SABS's Interest & Investment Income at $1.05 million (Q1 2026), $700,739 (Q4 2025) and $655,233 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | SAB Biotherapeutics | 248.81 Mn | 248.81 Mn | - | 1.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.71 Mn |
| Mar 31, 2026 | 1.05 Mn |
| Dec 31, 2025 | 700,739.00 |
| Sep 30, 2025 | 655,233.00 |
| Jun 30, 2025 | 14,000.00 |
| Mar 31, 2025 | 62,498.00 |
| Dec 31, 2024 | 136,374.00 |
| Sep 30, 2024 | 277,174.00 |
| Jun 30, 2024 | 374,557.00 |
| Mar 31, 2024 | 497,893.00 |
| Dec 31, 2023 | 484,046.00 |
| Sep 30, 2023 | 14,364.00 |
| Jun 30, 2023 | 28,568.00 |
| Mar 31, 2023 | 57,988.00 |
| Dec 31, 2022 | 29,929.00 |
| Sep 30, 2022 | 17,385.00 |
| Jun 30, 2022 | 15,824.00 |
| Mar 31, 2022 | 7,933.00 |
| Dec 31, 2021 | 8,544.00 |
| Sep 30, 2021 | 3,769.00 |
API Access
SAB Biotherapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();